Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
Third step of Clariane's four-legged debt restructuring plan was 1.67 times oversubscribed -
Evidence grows that companies can sell bonds successfully any day of the week
-
Valuation mismatch between issuer and investors prompted the decision to cancel the IPO
-
Online pharmacy concludes the issue of convertible bonds, a delta placement and a tender offer
-
The first IPO in more than three years probably won’t reignite the Portuguese market
-
Like Renk and Douglas, Galderma has turned to the loan market over bonds after floating
